Canadian pharmaceutical group Valeant is said to have increased the prices of Nitropress and Isuprel, by 525% and 212%, respectively, after purchasing the drugs. Several Democratic lawmakers in late September 2015 had pressed Valeant to provide documentation explaining the spike in its prices early in 2015 on these two drugs used for cardiac care.
The pharmaceutical group says it has received subpoenas from US federal prosecutors seeking information about the pricing and distribution of its drugs, along with how it makes them more affordable for patients. Valeant said, "We intends to cooperate with the authorities, which also want the company to provide details on information it gave to the Centers for Medicare and Medicaid Services."
Valeant Forces Rival to Pull Out of Bidding War
Endo was outbid in developing treatment for gastrointestinal diseases because, rival, Canadian pharmaceutical Valeant increased its offer for Salix.
Advertisement
The lawmakers, who have been investigating Valeant for several weeks now, are also seeking to have chief executive Michael Pearson testify.
Pearson said, "All of us at Valeant firmly believe in maintaining strong regulatory and financial controls and believe we have operated our business in a fully compliant manner. We remain committed to assisting eligible patients who need our products, and we will be working with the appropriate groups to submit the requested documents and plan to cooperate with the inquiries."
Source: AFP
Source: AFP
Researchers Clarify a Long-Standing Question in Cardiac Care
A decade ago, researchers from Brigham and Women's Hospital (BWH) demonstrated that a high dose statin, which lowered cholesterol further than a regular dose statin, provided better clinical outcomes.
Advertisement
 ACCA Mobile App on Emergency Cardiac Care Aids Best Decisions in SecondsThe ACCA Clinical Decision-Making Toolkit mobile app is now available on Google Play and the App Store. | Advertisement
|
Growth of Cardiac Services Linked to Competition, Not Patient Care
Study reveals that new interventional cardiac catheterization services offered by U.S. hospitals generally duplicate existing programs and do not help patients gain access to timely emergency cardiac care.
Advertisement
Recommended Reading
Latest Medico Legal News
The Delhi High court recently stated that it is not mandatory to conduct personal examination of the doctor who prepared Medico-legal cases (MLC).
The Supreme Court directed the Ministry of Health and Family Welfare, GoI to examine means to improve the conditions of persons suffering from Chronic Fatigue Syndrome.
The Orissa High Court has ordered the state government to ascertain as to whether every person practicing the medical profession has valid qualification.
The Supreme Court of the United Kingdom upheld a prohibition on pro-life protests and prayers inside a 328-foot radius outside of any abortion clinic in Northern Ireland.
The court said the state cannot restrain the right to health and right to life to its domiciles only. This right is available to a person and not restricted to a citizen.